ProtheraCytes express endothelial and cardiovascular markers
AMI
To further delineate the molecular signature of ProtheraCytes compared to naïve (unexpanded) CD34RNA expression levels detected by RNAseq analysis of ProtheraCytes from AMI patients versus healthy donors. PCA analysis (We next focused on analyzing the expression by flow cytometry of cell surface receptor markers previously found to be upregulated through our global study of mRNA expression by RNAseqFlow cytometry characterization of ProtheraCytes cell surface markers. (